SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $96,000 | -38.9% | 43,997 | +5.3% | 0.00% | 0.0% |
| Q2 2021 | $157,000 | +13.8% | 41,788 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $138,000 | -4.2% | 42,478 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $144,000 | -15.3% | 42,263 | +1.4% | 0.00% | -50.0% |
| Q3 2020 | $170,000 | +97.7% | 41,680 | +63.0% | 0.00% | +100.0% |
| Q2 2020 | $86,000 | +53.6% | 25,573 | +7.1% | 0.00% | 0.0% |
| Q1 2020 | $56,000 | -79.6% | 23,870 | -68.3% | 0.00% | -66.7% |
| Q4 2019 | $274,000 | -75.1% | 75,334 | -43.2% | 0.00% | -76.9% |
| Q3 2019 | $1,099,000 | -22.7% | 132,546 | -19.7% | 0.01% | -18.8% |
| Q2 2019 | $1,421,000 | -18.3% | 164,995 | +1.4% | 0.02% | -23.8% |
| Q1 2019 | $1,740,000 | +27.1% | 162,744 | +4.0% | 0.02% | +16.7% |
| Q4 2018 | $1,369,000 | -43.2% | 156,413 | +9.1% | 0.02% | -21.7% |
| Q3 2018 | $2,409,000 | -15.7% | 143,398 | +5.2% | 0.02% | -20.7% |
| Q2 2018 | $2,856,000 | +24.2% | 136,283 | -4.7% | 0.03% | +26.1% |
| Q1 2018 | $2,300,000 | -20.3% | 142,970 | -6.1% | 0.02% | -17.9% |
| Q4 2017 | $2,886,000 | +420.0% | 152,270 | +285.9% | 0.03% | +300.0% |
| Q3 2017 | $555,000 | +101.8% | 39,455 | +7.1% | 0.01% | +75.0% |
| Q2 2017 | $275,000 | +14.6% | 36,855 | -0.3% | 0.00% | +33.3% |
| Q1 2017 | $240,000 | +50.0% | 36,955 | +2.5% | 0.00% | +50.0% |
| Q4 2016 | $160,000 | -6.4% | 36,055 | -1.4% | 0.00% | -33.3% |
| Q3 2016 | $171,000 | -17.8% | 36,555 | +15.5% | 0.00% | 0.0% |
| Q2 2016 | $208,000 | +7.8% | 31,655 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $193,000 | +10.3% | 30,355 | +4.5% | 0.00% | +50.0% |
| Q4 2015 | $175,000 | +2.9% | 29,055 | +2.1% | 0.00% | 0.0% |
| Q3 2015 | $170,000 | -39.1% | 28,455 | -29.4% | 0.00% | -33.3% |
| Q4 2014 | $279,000 | -14.4% | 40,300 | +0.5% | 0.00% | -25.0% |
| Q3 2014 | $326,000 | +5.2% | 40,100 | +5.0% | 0.00% | 0.0% |
| Q2 2014 | $310,000 | +5.4% | 38,200 | +1.6% | 0.00% | 0.0% |
| Q1 2014 | $294,000 | -22.0% | 37,600 | -11.9% | 0.00% | -20.0% |
| Q4 2013 | $377,000 | -5.0% | 42,700 | -9.9% | 0.01% | 0.0% |
| Q3 2013 | $397,000 | +13.8% | 47,400 | +1.1% | 0.01% | 0.0% |
| Q2 2013 | $349,000 | -33.5% | 46,900 | -33.4% | 0.01% | -37.5% |
| Q1 2013 | $525,000 | – | 70,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |